» Articles » PMID: 36867428

Dipeptide-Derived Alkynes As Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins

Overview
Journal J Med Chem
Specialty Chemistry
Date 2023 Mar 3
PMID 36867428
Authors
Affiliations
Soon will be listed here.
Abstract

The potential of designing irreversible alkyne-based inhibitors of cysteine cathepsins by isoelectronic replacement in reversibly acting potent peptide nitriles was explored. The synthesis of the dipeptide alkynes was developed with special emphasis on stereochemically homogeneous products obtained in the Gilbert-Seyferth homologation for C≡C bond formation. Twenty-three dipeptide alkynes and 12 analogous nitriles were synthesized and investigated for their inhibition of cathepsins B, L, S, and K. Numerous combinations of residues at positions P1 and P2 as well as terminal acyl groups allowed for the derivation of extensive structure-activity relationships, which were rationalized by computational covalent docking for selected examples. The determined inactivation constants of the alkynes at the target enzymes span a range of >3 orders of magnitude (3-10 133 M s). Notably, the selectivity profiles of alkynes do not necessarily reflect those of the nitriles. Inhibitory activity at the cellular level was demonstrated for selected compounds.

Citing Articles

Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin-K Activity Detection, Revealing Nuclear Activity.

Dey G, Sinai-Turyansky R, Yakobovich E, Merquiol E, Loboda J, Sridharan N Adv Sci (Weinh). 2024; 11(38):e2401518.

PMID: 38970171 PMC: 11481179. DOI: 10.1002/advs.202401518.

References
1.
Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W . Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013; 27(3):221-34. DOI: 10.1007/s10822-013-9644-8. View

2.
Olson O, Joyce J . Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer. 2015; 15(12):712-29. DOI: 10.1038/nrc4027. View

3.
Robichaud J, Black W, Therien M, Paquet J, Oballa R, Bayly C . Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis. J Med Chem. 2008; 51(20):6410-20. DOI: 10.1021/jm800610j. View

4.
Schenker P, Alfarano P, Kolb P, Caflisch A, Baici A . A double-headed cathepsin B inhibitor devoid of warhead. Protein Sci. 2008; 17(12):2145-55. PMC: 2590916. DOI: 10.1110/ps.037341.108. View

5.
Lutzner N, Kalbacher H . Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate. J Biol Chem. 2008; 283(52):36185-94. PMC: 2662293. DOI: 10.1074/jbc.M806500200. View